HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Link between CFTR mutations and ABPA: a systematic review and meta-analysis.

Abstract
Summary  There is a biological plausibility on the link between cystic fibrosis transmembrane conductance regulator (CFTR) mutations and allergic bronchopulmonary aspergillosis (ABPA). The aim of the systematic review was to investigate this link by determining the frequency of CFTR mutations in ABPA. We searched the PubMed and EmBase databases for studies reporting CFTR mutations in ABPA. We pooled the odds ratio (OR) and 95% confidence intervals (CI) from individual studies using both fixed and random effects model. Statistical heterogeneity was evaluated using the I(2) test and the Cochran-Q statistic. Publication bias was assessed using both graphical and statistical methods. Our search yielded four studies (79 ABPA, 268 controls). The odds of encountering CFTR mutation was higher in ABPA compared with the control group (OR 10.39; 95% CI, 4.35-24.79) or the asthma population (OR 5.53; 95% CI 1.62-18.82). There was no evidence of statistical heterogeneity or publication bias. There is a possible pathogenetic link between CFTR mutations and ABPA. However, because of the small numbers of patients, further studies are required to confirm this finding. Future studies should adopt a uniform methodology and should screen for the entire genetic sequence of the CFTR gene.
AuthorsRitesh Agarwal, Ajmal Khan, Ashutosh N Aggarwal, Dheeraj Gupta
JournalMycoses (Mycoses) Vol. 55 Issue 4 Pg. 357-65 (Jul 2012) ISSN: 1439-0507 [Electronic] Germany
PMID21999194 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Copyright© 2011 Blackwell Verlag GmbH.
Chemical References
  • Cystic Fibrosis Transmembrane Conductance Regulator
Topics
  • Aspergillosis, Allergic Bronchopulmonary (genetics)
  • Asthma (complications, genetics)
  • Cystic Fibrosis (complications, genetics)
  • Cystic Fibrosis Transmembrane Conductance Regulator (genetics)
  • Genetic Predisposition to Disease
  • Humans
  • Mutation
  • Publication Bias

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: